Structure via PubChem · Public domain (PubChem)
AL-38022A
Sign in to saveAL-38022A is a serotonin receptor agonist and psychedelic drug of the indazolethylamine family related to the psychedelic tryptamine 5-MeO-AMT. It is one of a range of similar drugs developed for scientific research and with some possible clinical applications such as in the treatment of glaucoma. The drug acts as a potent and selective agonist for the 5-HT2 family of serotonin receptors, with highest binding affinity for the 5-HT2C subtype and around four times less affinity for 5-HT2A and 5-HT2B. In drug discrimination tests in animals, it fully substituted for the psychedelic drugs 5-MeO-DM
In the Vinony graph
Within Vinony's link graph, AL-38022A is referenced by 1,767 other articles, and connects out to tryptamines, N-methylserotonin and 5-methoxytryptamine.
It sits within the topics 5-HT2A agonists, 5-HT2B agonists and 5-HT2C agonists.
Its subject is documented across 4 Wikipedia language editions.
Chemical data
- Formula
- C13H17N3O
- Molecular weight
- 231.29 g/mol
- IUPAC name
- 1-(8,9-dihydro-7H-pyrano[2,3-g]indazol-1-yl)propan-2-amine
- SMILES
- CC(CN1C2=C(C=CC3=C2CCCO3)C=N1)N
- InChIKey
- FJRIVFVALIEIOY-UHFFFAOYSA-N
- XLogP
- 1.4
- Polar surface area
- 53.1 Ų
- H-bond donors
- 1
- H-bond acceptors
- 3
- Formal charge
- 0
via PubChem
Wikidata facts
- Subclass of
- chemical compound
- Mass
- 231.137162164
Show 3 more facts
- chemical formula
- C₁₃H₁₇N₃O
- canonical SMILES
- CC(CN1C2=C(C=CC3=C2CCCO3)C=N1)N
- Commons category
- AL-38022A
via Wikidata · CC0
~1 min read
Encyclopedic overview
3 sectionsContents
- See also
- References
- External links
AL-38022A is a serotonin receptor agonist and psychedelic drug of the indazolethylamine family related to the psychedelic tryptamine 5-MeO-AMT. It is one of a range of similar drugs developed for scientific research and with some possible clinical applications such as in the treatment of glaucoma. The drug acts as a potent and selective agonist for the 5-HT2 family of serotonin receptors, with highest binding affinity for the 5-HT2C subtype and around four times less affinity for 5-HT2A and 5-HT2B. In drug discrimination tests in animals, it fully substituted for the psychedelic drugs 5-MeO-DMT and DOM. AL-38022A was first described in the scientific literature by Richard Glennon and colleagues in 2009.
==See also== Indazolethylamine Substituted tryptamine § Related compounds AL-34662 AL-37350A O-Methyl-AL-34662 Ro60-0175 VER-3323 YM-348
Excerpted from Wikipedia’s “AL-38022A” article, available under the CC BY-SA 4.0 licence.